首页> 外文期刊>Medical image analysis >SDAE-GAN: Enable high-dimensional pathological images in liver cancer survival prediction with a policy gradient based data augmentation method
【24h】

SDAE-GAN: Enable high-dimensional pathological images in liver cancer survival prediction with a policy gradient based data augmentation method

机译:Sdae-GaN:通过基于政策梯度的数据增强方法使肝癌生存预测中的高尺寸病理图像能够实现

获取原文
获取原文并翻译 | 示例
           

摘要

High-dimensional pathological images produced by Immunohistochemistry (IHC) methods consist of many pathological indexes, which play critical roles in cancer treatment planning. However, these indexes currently cannot be utilized in survival prediction because joining them with patients' clinicopathological features (e.g., age and tumor size) is challenging due to their high dimension and sparse features. To address this problem, we propose a novel two-stage survival prediction model named ICSPM to join the IHC images and clinicopathological features. For the first stage, our proposed SDAE-GAN compresses high-dimensional IHC images to flat, compact and representative feature vectors by compressing and reconstructing them. For the first time, SDAE-GAN integrates dense blocks, the stacked auto-encoder and the GAN architecture to maximize the ability to detect patterns in IHC images. In addition, we propose a novel policy gradient based data augmentation method to involve the diversity in IHC images without breaking patterns inside them. For the second stage, ICSPM adopts a DenseNet to join feature vectors and clinicopathological features for survival prediction. Experimental results demonstrate that ICSPM reached a state-of-the-art prediction accuracy of 0.72 on the five-year survival. ICSPM is the first work to enable high-dimensional IHC images in cancer survival prediction. We prove that high-dimensional IHC images and clinicopathological features provide valuable and complementary information in survival prediction. (C) 2020 Elsevier B.V. All rights reserved.
机译:免疫组织化学(IHC)方法产生的高尺寸病理学图像由许多病理指标组成,其在癌症治疗计划中起重要作用。然而,这些指标目前不能用于存活预测,因为在患者的临床病理特征(例如,年龄和肿瘤大小)由于其高尺寸和稀疏特征而挑战。为了解决这个问题,我们提出了一种名为ICSPM的新型两阶段生存预测模型,加入IHC图像和临床病理特征。对于第一阶段,我们提出的SDAE-GaN通过压缩和重建它们将高维IHC图像压缩为平坦的,紧凑和代表特征向量。首次,SDAE-GAN集成了密集块,堆叠的自动编码器和GAN架构,以最大化检测IHC图像中模式的能力。此外,我们提出了一种新的政策梯度基础的数据增强方法,涉及IHC图像中的多样性而不破坏它们内部的模式。对于第二阶段,ICSPM采用DENSENET加入特征载体和临床病理特征以进行生存预测。实验结果表明,ICSPM在五年生存率上达到了0.72的最先进的预测精度。 ICSPM是第一个能够在癌症生存预测中启用高维IHC图像的工作。我们证明了高维IHC图像和临床病理学特征在生存预测中提供了有价值的信息和互补的信息。 (c)2020 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号